Stem Cells · Knowledge & Cooperation
AURELIA / STEM CELLS

Stem Cells Knowledge & Cooperation

From a clear explanation to evidence and a concrete cooperation brief.

SEE / UNDERSTAND / ASK

Understand the science visually

Open any image at full size. Research pictures, original schematics and generated concepts are labelled separately; none is an Aurelia patient outcome.

Self-renewal and differentiation — Simplified teaching schematic; cell identity and requirements depend on the actual cell type and intended use.
Principle schematic

Self-renewal and differentiation

Simplified teaching schematic; cell identity and requirements depend on the actual cell type and intended use.

Original schematic · Aurelia · Scientific reference ↗
Human iPSC colony — Confocal image of an OCA1A research model. OCT4 is red, SSEA4 green and nuclei blue; this is not a treatment result.
Published research image

Human iPSC colony

Confocal image of an OCA1A research model. OCT4 is red, SSEA4 green and nuclei blue; this is not a treatment result.

NIH Image Gallery from Bethesda, Maryland, USA · Public domain
Image source ↗ · Original research / source ↗
Format and display notes

保留完整画幅和原有标注,仅等比例缩小并转WebP;原始文件同时保留。

Human umbilical-cord MSCs — Primary-culture morphology from different human umbilical-cord regions. A laboratory comparison, not clinical efficacy data.
Published research image

Human umbilical-cord MSCs

Primary-culture morphology from different human umbilical-cord regions. A laboratory comparison, not clinical efficacy data.

Subramanian A, Fong C-Y, Biswas A, Bongso A · CC BY 4.0
Image source ↗ · Original research / source ↗
Format and display notes

保留完整画幅和原有标注,仅等比例缩小并转WebP;原始文件同时保留。

KNOWLEDGE / EVIDENCE / PARTNERSHIP

Not one cell Not one treatment

Blood-forming stem cells, MSCs and pluripotent-cell-derived products have distinct uses and evidence. We separate education, published outcomes and institutional cooperation so the details can be assessed.

A concrete institutional conversation

Joint research, licensing, process transfer and clinic planning need different scopes. Start with your institution, region, stage and goal. Review science, rights, quality and local permissions before execution.

Cooperation models & requirements

Questions & answers

Does technology licensing authorise treatment?

No. IP licensing and clinical authorisation are distinct. Intended use, evidence, quality systems and local regulatory requirements need separate review.